Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses
Nanovaccines, co-delivering antigen and invariant natural killer T (iNKT) cell agonists, proved to be very effective in inducing anti-tumor T cell responses due to their exceptional helper function. However, it is known that iNKT cells are not equally present in all lymphoid organs and nanoparticles...
Main Authors: | Yusuf Dölen, Michael Valente, Oya Tagit, Eliezer Jäger, Eric A. W. Van Dinther, N. Koen van Riessen, Martin Hruby, Uzi Gileadi, Vincenzo Cerundolo, Carl G. Figdor |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1738813 |
Similar Items
-
iNKT and MAIT cell alterations in diabetes
by: Isabelle eMagalhaes, et al.
Published: (2015-07-01) -
License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity
by: Angélica Díaz-Basabe, et al.
Published: (2020-05-01) -
iNKT Cells and Their potential Lipid Ligands during Viral Infection
by: Anunya eOpasawatchai, et al.
Published: (2015-07-01) -
Etapes de maturation et mécanismes de régulation déterminant le sous-lignage des cellules iNKT17
by: Joseph, Claudine
Published: (2017) -
Cytokine Output of Adipocyte-iNKT Cell Interplay Is Skewed by a Lipid-Rich Microenvironment
by: Robert J. van Eijkeren, et al.
Published: (2020-07-01)